Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Director Dealing

2 Apr 2015 07:00

RNS Number : 2552J
PuriCore Plc
02 April 2015
 



PuriCore plc ("PuriCore" or the "Company")

 

Director Dealing

 

2 April 2015 - PuriCore plc (AIM: PURI), an international company focused on safe and effective protection against the spread of infectious pathogens, today announces a director dealing, in accordance with the Disclosure and Transparency Rules. On 1 April 2015, the following Director notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares"), as set out below.

 

 

 

Name

Date purchased

Number of Shares purchased

Purchase price of Shares

Shareholding following the acquisition

% of issued share capital

Charles SpicerNon-Executive Chairman

1 Apr 2014

 

50,610

 

32p

 

75,000

 

0.15%

 

 

-Ends-

 

Enquiries:

 

PuriCore plc

+44 (0) 20 3727 1000

Michael Ashton, Chief Executive Officer

Marella Thorell, Chief Financial Officer and Chief Operating Officer

FTI Consulting

+44 (0) 20 3727 1000

Simon Conway / Mo Noonan / Victoria Foster Mitchell

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Aubrey Powell / Jen Boorer / Thomas Smale

 

 

About PuriCore

PuriCore is an international company focused on developing and commercialising safe and effective products to protect against the spread of infectious pathogens based on its proprietary hypochlorous acid platform technology. Its products are currently used in two broad market segments: Supermarket Retail and Health Sciences. PuriCore's products do not cause harm to human or animal life or to the environment.

 

In the Supermarket Retail segment, PuriCore offers products to US retailers for use in their fresh produce departments to improve food safety and quality, to extend shelf life and to decrease food wastage. Our product is an eco-friendly, food-safe sanitising solution at a neutral PH that is used to protect produce from cross contamination and improve freshness. Our Sterilox Fresh Systems are capital equipment that are installed at customer locations and allow for generation of solution as needed at the store. ProduceFresh is our concentrate bottled version providing the same levels of stability, freshness and quality in a convenient consumable package. Additionally, the Company's FloraFresh products, also sold as a concentrate in bottled form, protect against fungal growth and extend the life of cut flowers, with an initial focus on supermarket floral departments.

 

In Health Sciences, PuriCore's Wound Care business provides products that are used to treat chronic and acute wounds, including diabetic ulcers and burns in humans. A range of products have also been developed to manage wounds in companion and farm animals. The Company's Dermatology business is currently focused on treatments for atopic dermatitis. PuriCore is headquartered in Malvern, Pennsylvania.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUGUQGCUPAPPG
Date   Source Headline
11th Jun 20072:32 pmRNSPresenting at Conference
11th Jun 200712:18 pmRNSHolding(s) in Company
31st May 200710:14 amRNSResult of AGM
23rd May 200712:00 pmBUSFDA Lists Sterilox Food Safety Solution for Food Contact
23rd May 20077:02 amRNSRe: Food Safety Solution
21st May 200712:00 pmBUSStudy Shows PuriCore's Aquatine(TM) EC Effective for Root Canal Disinfecting and Cleansing
14th May 20075:57 pmRNSAnnual Information Update
25th Apr 20079:14 amRNSDirector/PDMR Shareholding
19th Apr 200710:45 amRNSHolding(s) in Company
19th Apr 20079:54 amRNSDirector/PDMR Shareholding
18th Apr 20074:00 pmRNSHolding(s) in Company
18th Apr 20077:01 amRNSDirector/PDMR Shareholding
16th Apr 20077:02 amRNSFinal Results
5th Apr 200712:00 pmBUSPuriCore Receives FDA 510(k) Approval for Endoscope Disinfectant System in US
5th Apr 20077:01 amRNSFDA 510(k) Approval
29th Mar 20078:00 amRNSNotice of Results
27th Mar 20071:54 pmBUSPuriCore signs additional endoscope reprocessor marketing partnership
27th Mar 20071:02 pmRNSSigns Marketing Partnership
5th Mar 20075:12 pmRNSHolding(s) in Company
5th Feb 20077:01 amRNSRe Agreement
5th Feb 20077:01 amRNSTrading Update
26th Jan 20073:44 pmRNSRe: Section 198
8th Jan 20077:00 amRNSFundraising
18th Dec 20064:01 pmRNSTransparency Rule
8th Dec 20062:00 pmRNSGreg Bosch Wins CEO of Year
13th Nov 20067:02 amRNSAppointment
7th Nov 20063:47 pmRNSRe Interest in Shares
7th Nov 20063:44 pmRNSInterest in Shares
13th Sep 20067:03 amRNSAppointments
13th Sep 20067:03 amRNSContract
13th Sep 20067:03 amRNSInterim Results
21st Aug 200611:05 amRNSHolding(s) in Company
16th Aug 200611:12 amRNSNotice of Results
7th Aug 20063:43 pmRNSBlocklisting Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.